Abstract
Glycorandomization is a chemoenzymatic strategy that overcomes the limitations in natural product derivatization associated with both solely chemistry-based approaches or in vivo engineering. In this article we present the basic strategies for glycorandomization development as a next-generation tool in drug discovery.
Original language | English |
---|---|
Pages (from-to) | 1577-1584 |
Number of pages | 8 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 12 |
Issue number | 7 |
DOIs | |
State | Published - Apr 1 2004 |
Bibliographical note
Funding Information:This contribution was supported in part by the National Institutes of Health (GM58196, CA84374 and AI52218). D.H. is research fellow of the Deutsche Forschungsgemeinschaft (DFG)
Keywords
- Antibiotics
- Enzyme catalysis
- Galactokinase
- Glycosyltransferase
- Natural products
- Nucleotidylyltransferase
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry